California's legislature concluded its August 31 session by enrolling multiple healthcare bills addressing AI in clinical care, prior authorization practices, and coverage expansion. Key legislation includes AB 1979 requiring professional judgment for AI clinical decisions, AB 1887 mandating 30-day prior authorization for rare disease drugs effective January 1, 2027, and SB 1089 expanding GLP-1 medication access through the state's CALRx purchasing program.